Ru Li

Ru Li

Direttore/Membro del Consiglio presso CHONGQING TAIJI INDUSTRY(GROUP) CO.,LTD
47 anni
Health Technology
Consumer Services

Profilo

Ru Li currently works at Shanghai Shyndec Pharmaceutical Co., Ltd., as Director from 2022, China National Pharmaceutical Group Co., Ltd., as Deputy Director & Director-Risk & Operation from 2012, Sinopharm Common Wealth Co. Ltd., as Director, Chongqing Taiji Industry (Group) Co., Ltd., as Member-Supervisory Board from 2021, and China National of Traditional & Herbal Medicine Co., Ltd., as Member-Supervisory Board.
Ms. Li also formerly worked at China Traditional Chinese Medicine Holdings Co. Ltd., as Non-Executive Director from 2019 to 2025, Takeda AS, as Market Manager from 2010 to 2012, and China National Medicines Co., Ltd., as Manager-Product, Regional & Divisional Sales from 2001 to 2010.
Ms. Li received her undergraduate degree in 2001 from Shenyang Pharmaceutical University.

Posizioni attive di Ru Li

SocietàPosizioneInizio
CHONGQING TAIJI INDUSTRY(GROUP) CO.,LTD Direttore/Membro del Consiglio 19/05/2021
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Direttore/Membro del Consiglio 28/11/2022
Direttore/Membro del Consiglio -
Corporate Officer/Principal 01/01/2012

Precedenti posizioni note di Ru Li

SocietàPosizioneFine
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED Direttore/Membro del Consiglio 15/01/2025
Vendite & Marketing 01/01/2012
CHINA NATIONAL MEDICINES CORPORATION LTD. Corporate Officer/Principal 01/01/2010
Vedi nel dettaglio l'esperienza di Ru Li

Formazione di Ru Li

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

43

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services